A novel strategy for cancer therapy by mutated mammalian degenerin gene transfer
Masayoshi Horimoto(The University of Osaka), Masatsugu Hori(The University of Osaka), Yutaka Sasaki(The University of Osaka), Mahito Nakanishi(Tokiwa University), Takayuki Yakushijin(The University of Osaka), Takashi Toyama(Tohoku University), Shinya Ugawa(Nagoya City University), Akiko Eguchi(Mie University), Yuki Minami(The University of Osaka), Kenya Iyoda(The University of Osaka), Shigeo Wada(The University of Osaka), Taizo Hijioka(Osaka Minami Medical Center), Toshifumi Ito(The University of Osaka), Masaya Tohyama(Institute for Women's Policy Research), Shoichi Shimada(The University of Osaka), Norio Hayashi(The University of Osaka)
Cited by 10
Related Papers
Characterization of oligonucleotide transport into living cells.
|Proceedings of the National Academy of Sciences|1989|740
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
|Cell stem cell|2013|412
An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease
|Nature|1997|376
Development of Defective and Persistent Sendai Virus Vector
|Journal of Biological Chemistry|2010|373